Urocortin's inhibition of tumor growth and angiogenesis in hepatocellular carcinoma via corticotrophin-releasing factor receptor 2

Urocortin (UCN) functions via corticotrophin-releasing factor receptors (CRFRs), CRFR1 & 2. CRFR2 is reported to be a tonic suppressor of vascularization, implying its role in tumor angiogenesis. Here, it was found that UCN inhibited the growth of hepatocellular carcinoma (HCC) and reduced tumor microvessel density in nude mice. Hepatoma cells didn't express CRFRs whereas vessels expressed CRFRs, mainly CRFR2. In vitro three-dimensional culture assay showed UCN inhibited angiogenesis, this effect was abolished by CRFR2 antagonist, anti-sauvagine-30, demonstrating involvement of CRFR2. Furthermore, UCN inhibited the proliferation and promoted the apoptosis of endothelial cells and down-regulated VEGF expression in vivo via CRFR2.

Medienart:

E-Artikel

Erscheinungsjahr:

2008

Erschienen:

2008

Enthalten in:

Zur Gesamtaufnahme - volume:26

Enthalten in:

Cancer investigation - 26(2008), 4 vom: 29. Mai, Seite 359-68

Sprache:

Englisch

Beteiligte Personen:

Wang, Juejin [VerfasserIn]
Xu, Youhua [VerfasserIn]
Xu, Yinyan [VerfasserIn]
Zhu, Huayuan [VerfasserIn]
Zhang, Rongjian [VerfasserIn]
Zhang, Guoxin [VerfasserIn]
Li, Shengnan [VerfasserIn]

Links:

Volltext

Themen:

CRF receptor type 2
Journal Article
Neoplasm Proteins
Receptors, Corticotropin-Releasing Hormone
Research Support, Non-U.S. Gov't
Urocortins
VEGFA protein, human
Vascular Endothelial Growth Factor A
Vascular endothelial growth factor A, mouse

Anmerkungen:

Date Completed 02.06.2008

Date Revised 29.04.2008

published: Print

Citation Status MEDLINE

doi:

10.1080/07357900701788106

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM179228145